Group 1 - Key Point 1: As of October 29, 2025, a total of 12 institutional investors hold shares in Kexing Pharmaceutical (688136.SH), with a combined holding of 119 million shares, representing 59.24% of the total share capital [1] - Key Point 2: The top ten institutional investors account for a combined holding ratio of 59.23%, with a decrease of 13.28 percentage points compared to the previous quarter [1] Group 2 - Key Point 1: In the current period, four public funds increased their holdings, accounting for an increase of 0.21% [2] - Key Point 2: Two public funds reduced their holdings, with a decrease of 1.33% compared to the previous quarter [2] - Key Point 3: Three new public funds were disclosed in the current period, while 156 public funds were not disclosed in the current quarter [2]
机构风向标 | 科兴制药(688136)2025年三季度已披露前十大机构持股比例合计下跌13.28个百分点